Lanzogast 30
Gastro-intestinal Drugs

Lanzogast 30 | Capsules

Form:

Capsules

Strength:

30 mg

Each Lanzogast Capsule contains: Lansoprazole as Enteric Coated Pellets 30 mg.

Product Overview

Indications:
Lanzogast is indicated for the treatment or prevention of gastric and duodenal ulcers, erosive esophagitis, and other conditions associated with excessive gastric acid secretion, such as Zollinger–Ellison syndrome.

Dosage and method of administration:
The recommended dose (without prescription) is one capsule daily for 14 days (for more information, see the enclosed leaflet).

Specifications

Composition
Lansoprazole
Dosage Form
Capsules
Strength
30 mg
Therapeutic Category
Gastro-intestinal Drugs
Packaging Type
Blister
Storage Conditions
Store in a dry place at a temperature below 25°C.

Regulatory & Safety Documents

Document
Lanzogast leaflet.pdf
PDF Document • 528.96 KB
×